Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mimedx (MDXG) Short term Debt (2016 - 2025)

Mimedx's Short term Debt history spans 9 years, with the latest figure at $1.5 million for Q4 2025.

  • For Q4 2025, Short term Debt rose 50.0% year-over-year to $1.5 million; the TTM value through Dec 2025 reached $1.5 million, up 50.0%, while the annual FY2025 figure was $1.5 million, 50.0% up from the prior year.
  • Short term Debt for Q4 2025 was $1.5 million at Mimedx, up from $1.4 million in the prior quarter.
  • Across five years, Short term Debt topped out at $2.9 million in Q3 2024 and bottomed at $1.0 million in Q4 2023.
  • The 3-year median for Short term Debt is $1.2 million (2025), against an average of $1.5 million.
  • The largest YoY upside for Short term Debt was 50.0% in 2025 against a maximum downside of 51.92% in 2025.
  • A 3-year view of Short term Debt shows it stood at $1.0 million in 2023, then changed by 0.0% to $1.0 million in 2024, then soared by 50.0% to $1.5 million in 2025.
  • Per Business Quant, the three most recent readings for MDXG's Short term Debt are $1.5 million (Q4 2025), $1.4 million (Q3 2025), and $1.2 million (Q2 2025).